Generic Rx Reforms: No Automatic “Controversy” For Declaratory Judgments

The Medicare conference bill's Waxman/Hatch reform provisions would require federal courts to determine whether declaratory judgment actions brought by ANDA filers against innovators are a "case or controversy" under the Constitution